These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 35204690)
1. Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications. Kasheverov I; Kudryavtsev D; Shelukhina I; Nikolaev G; Utkin Y; Tsetlin V Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204690 [TBL] [Abstract][Full Text] [Related]
2. Natural compounds interacting with nicotinic acetylcholine receptors: from low-molecular weight ones to peptides and proteins. Kudryavtsev D; Shelukhina I; Vulfius C; Makarieva T; Stonik V; Zhmak M; Ivanov I; Kasheverov I; Utkin Y; Tsetlin V Toxins (Basel); 2015 May; 7(5):1683-701. PubMed ID: 26008231 [TBL] [Abstract][Full Text] [Related]
3. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors. Tsetlin V; Utkin Y; Kasheverov I Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053 [TBL] [Abstract][Full Text] [Related]
4. Naturally occurring and synthetic peptides acting on nicotinic acetylcholine receptors. Kasheverov IE; Utkin YN; Tsetlin VI Curr Pharm Des; 2009; 15(21):2430-52. PubMed ID: 19601841 [TBL] [Abstract][Full Text] [Related]
5. Oligoarginine Peptides, a New Family of Nicotinic Acetylcholine Receptor Inhibitors. Lebedev DS; Kryukova EV; Ivanov IA; Egorova NS; Timofeev ND; Spirova EN; Tufanova EY; Siniavin AE; Kudryavtsev DS; Kasheverov IE; Zouridakis M; Katsarava R; Zavradashvili N; Iagorshvili I; Tzartos SJ; Tsetlin VI Mol Pharmacol; 2019 Nov; 96(5):664-673. PubMed ID: 31492697 [TBL] [Abstract][Full Text] [Related]
6. Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models. Kryukova EV; Ivanov IA; Lebedev DS; Spirova EN; Egorova NS; Zouridakis M; Kasheverov IE; Tzartos SJ; Tsetlin VI Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469507 [TBL] [Abstract][Full Text] [Related]
7. The Structural Features of α-Conotoxin Specifically Target Different Isoforms of Nicotinic Acetylcholine Receptors. Wu RJ; Wang L; Xiang H Curr Top Med Chem; 2015; 16(2):156-69. PubMed ID: 26126912 [TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors. Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616 [TBL] [Abstract][Full Text] [Related]
9. Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors. Molgó J; Aráoz R; Benoit E; Iorga BI Expert Opin Drug Discov; 2013 Oct; 8(10):1203-23. PubMed ID: 23919818 [TBL] [Abstract][Full Text] [Related]
11. [Natural alpha-conotoxins and their synthetic analogues in studies of nicotinic acetylcholine receptors]. Kasheverov IE; Utkin IuN; Tsetlin VI Bioorg Khim; 2006; 32(2):115-29. PubMed ID: 16637282 [TBL] [Abstract][Full Text] [Related]
12. Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads. Armishaw CJ Toxins (Basel); 2010 Jun; 2(6):1471-99. PubMed ID: 22069647 [TBL] [Abstract][Full Text] [Related]
13. Globular and ribbon isomers of Conus geographus α-conotoxins antagonize human nicotinic acetylcholine receptors. Tae HS; Gao B; Jin AH; Alewood PF; Adams DJ Biochem Pharmacol; 2021 Aug; 190():114638. PubMed ID: 34062129 [TBL] [Abstract][Full Text] [Related]
14. Species specificity of rat and human α7 nicotinic acetylcholine receptors towards different classes of peptide and protein antagonists. Yu J; Zhu X; Zhang L; Kudryavtsev D; Kasheverov I; Lei Y; Zhangsun D; Tsetlin V; Luo S Neuropharmacology; 2018 Sep; 139():226-237. PubMed ID: 30025921 [TBL] [Abstract][Full Text] [Related]
15. Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors. López-Vera E; Aguilar MB; Schiavon E; Marinzi C; Ortiz E; Restano Cassulini R; Batista CV; Possani LD; Heimer de la Cotera EP; Peri F; Becerril B; Wanke E FEBS J; 2007 Aug; 274(15):3972-85. PubMed ID: 17635581 [TBL] [Abstract][Full Text] [Related]
16. α-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors. Giribaldi J; Dutertre S Neurosci Lett; 2018 Jul; 679():24-34. PubMed ID: 29199094 [TBL] [Abstract][Full Text] [Related]
17. Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms. Dutertre S; Nicke A; Tsetlin VI Neuropharmacology; 2017 Dec; 127():196-223. PubMed ID: 28623170 [TBL] [Abstract][Full Text] [Related]
18. A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists. Armishaw CJ; Singh N; Medina-Franco JL; Clark RJ; Scott KC; Houghten RA; Jensen AA J Biol Chem; 2010 Jan; 285(3):1809-21. PubMed ID: 19901032 [TBL] [Abstract][Full Text] [Related]
19. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins. Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000 [TBL] [Abstract][Full Text] [Related]
20. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist. Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]